Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

ASCO 2017: Rate of Severe Health Problems Drops for Childhood Cancer Survivors

By Kenny Walter | June 6, 2017

An examination of cancer survivors from the 1970s to the 1990s shows that the rate of severe health problems occurring five or more years after diagnosis has declined over time.

The study— presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting—analyzed 23,600 childhood cancer survivors in the Childhood Cancer Survivor Study (CCSS) and found that the rate of severe health problems dropped from 12.7 percent for those diagnosed in the 1970s to 10.1 percent in the 1980s, to 8.8 percent for survivors diagnosed in the 1990s.

The rate of survivors of Wilms’ tumor—a rare kidney cancer—dropped from 13 percent in the 1970s to 5 percent in 1990s. Over the course of the survey the rate of survivors of Hodgkin lymphoma decreased from 18 percent to 11 percent, the rate for survivors of astrocytoma fell from 15 percent to 9 percent, from 10 percent to 6 percent among survivors of non-Hodgkin lymphoma and from 9 percent to 7 percent among survivors of acute lymphoblastic leukemia.

According to the study, advances in treatment and supportive care have improved the five-year survival rate after childhood cancer diagnosis from 58 percent in the 1970’s to 84 percent today. Previous research showed that changes in treatment over the last three decades lowered the chance of dying from late effects of therapy among childhood cancer survivors by 6.4 percent.

“Our analysis marks the first comprehensive assessment of changes in the rates of chronic health complications over time in a large group of cancer survivors,” lead study author Todd Gibson, Ph.D., an assistant member at St. Jude Children’s Research Hospital in Memphis, said in a statement. “From our findings, it is clear that survivors diagnosed and treated in more modern treatment eras are doing better.

“Not only are more children being cured, but they also have lower risk for developing serious health problems due to cancer treatment later in life,” he added.

The CCSS used periodic surveys to explore long-term outcomes in survivors of childhood cancer diagnosed between 1970 and 1999 that survived at least five years after diagnosis, focusing on severe, disabling, life-threatening or fatal health problems occurring within 15 years of the diagnosis.

While the researchers saw a decrease in health issues for survivors of several forms of cancer, they did not see a reduction among survivors of other types of cancer including neuroblastoma, acute myeloid leukemia, soft-tissue sarcoma and osteosarcoma.

They did however see great reductions in the incidence of endocrine conditions, which went from 4 percent in the 1970s to 1.6 percent in the 1990s and second cancers, which fell from 2.4 percent in the 1970s to 1.6 percent in the 1990s. There was also a significant reduction in gastrointestinal conditions and neurological conditions over the course of the survey, while the rate of heart or lung conditions did not change.

“We were a little surprised that the incidence of severe cardiovascular disease did not decrease, knowing that deaths from cardiovascular disease dropped among survivors in recent decades,” Gibson said. “This is a reminder that survivors continue to have an increased risk for serious health problems compared to the general population and need to be followed closely.”

The researchers now plan to study specific health conditions further and would also like to follow survivors beyond 15 years after diagnosis and study how late treatment effects intersect with aging.

The abstract can be viewed here.

Related Articles Read More >

professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
Health-related innovation in Morocco highlighted by resident inventor patenting activity
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE